Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:

Details Of Insider Trading Activities
TransactionCompanyTickerInsiderShares TradedAvg.
Price
Total ValueFiling
2019-09-04
Sale
Eidos Therapeutics, Inc.EIDXTurtle Cameron
Chief Business Officer
5,000$41.58$207,900
2019-08-15
Sale
Eidos Therapeutics, Inc.EIDXFox Jonathan C
See Remarks
5,000$38.72$193,600
2019-07-25
Sale
Eidos Therapeutics, Inc.EIDXSinha Uma
Chief Scientific Officer
5,000$36.13$180,650
2019-07-15
Sale
Eidos Therapeutics, Inc.EIDXFox Jonathan C
See Remarks
15,000$40.04$600,600
2019-07-10
Sale
Eidos Therapeutics, Inc.EIDXSiu Christine
CFO and Secretary
5,000$39.37$196,850
2019-07-03
Purchase
Eidos Therapeutics, Inc.EIDXBridgeBio Pharma, Inc.
10% owner
882,353$29.90$26,382,354
2019-07-03
Purchase
Eidos Therapeutics, Inc.EIDXAGUIAR ERIC
Director, 10% owner
882,353$29.90$26,382,354
2019-07-03
Purchase
Eidos Therapeutics, Inc.EIDXSatvat Ali J.
Director, 10% owner
882,353$29.90$26,382,354
2019-07-03
Purchase
Eidos Therapeutics, Inc.EIDXKumar Neil
Chief Executive Officer, Director, 10% owner
882,353$29.90$26,382,354
2019-06-05
Sale
Eidos Therapeutics, Inc.EIDXSiu Christine
CFO and Secretary
17,000$29.97$509,490
2019-06-04
Sale
Eidos Therapeutics, Inc.EIDXTurtle Cameron
Chief Business Officer
10,000$31.64$316,400
2019-05-30
Sale
Eidos Therapeutics, Inc.EIDXFox Jonathan C
See Remarks
5,000$32.64$163,200
2019-05-24
Purchase
Eidos Therapeutics, Inc.EIDXBridgeBio Pharma, Inc.
10% owner
1,103,848$25.93$28,622,778
2019-05-24
Purchase
Eidos Therapeutics, Inc.EIDXAGUIAR ERIC
Director, 10% owner
1,103,848$25.93$28,622,778
2019-05-24
Purchase
Eidos Therapeutics, Inc.EIDXKumar Neil
Chief Executive Officer, Director, 10% owner
1,103,848$25.93$28,622,778
2019-05-24
Purchase
Eidos Therapeutics, Inc.EIDXSatvat Ali J.
Director, 10% owner
1,103,848$25.93$28,622,778
2019-05-23
Sale
Eidos Therapeutics, Inc.EIDXSinha Uma
Chief Scientific Officer
5,000$27.28$136,400
2019-05-03
Sale
Eidos Therapeutics, Inc.EIDXFox Jonathan C
See Remarks
5,000$25.03$125,150
2019-05-01
Sale
Eidos Therapeutics, Inc.EIDXFox Jonathan C
See Remarks
5,000$25.46$127,300
2019-04-24
Sale
Eidos Therapeutics, Inc.EIDXSiu Christine
CFO and Secretary
5,000$26.11$130,550
2019-04-15
Sale
Eidos Therapeutics, Inc.EIDXFox Jonathan C
See Remarks
5,000$23.11$115,550
2019-03-19
Sale
Eidos Therapeutics, Inc.EIDXSiu Christine
CFO and Secretary
11,913$19.66$234,209
2018-12-10
Purchase
Eidos Therapeutics, Inc.EIDXBridgeBio Pharma LLC
10% owner
40,653$13.33$541,904
2018-12-10
Purchase
Eidos Therapeutics, Inc.EIDXBridgeBio Pharma LLC
10% owner
40,653$13.33$541,904
2018-12-07
Purchase
Eidos Therapeutics, Inc.EIDXBridgeBio Pharma LLC
10% owner
41,174$13.99$576,024
2018-12-07
Purchase
Eidos Therapeutics, Inc.EIDXBridgeBio Pharma LLC
10% owner
41,174$13.99$576,024
2018-12-06
Purchase
Eidos Therapeutics, Inc.EIDXBridgeBio Pharma LLC
10% owner
38,970$13.34$519,859
2018-12-06
Purchase
Eidos Therapeutics, Inc.EIDXBridgeBio Pharma LLC
10% owner
38,970$13.34$519,859
2018-12-05
Purchase
Eidos Therapeutics, Inc.EIDXBridgeBio Pharma LLC
10% owner
1,103,848$14.01$15,464,910
2018-12-03
Purchase
Eidos Therapeutics, Inc.EIDXBridgeBio Pharma LLC
10% owner
1,750,000$15.50$27,125,000
2018-06-22
Purchase
Eidos Therapeutics, Inc.EIDXSatvat Ali J.
Director, 10% owner
1,000,000$17.00$17,000,000
2018-06-22
Purchase
Eidos Therapeutics, Inc.EIDXKumar Neil
Chief Executive Officer, Director, 10% owner
1,000,000$17.00$17,000,000
2018-06-22
Purchase
Eidos Therapeutics, Inc.EIDXShah Rajeev M.
Director
1,058,824$17.00$18,000,008
2018-06-22
Purchase
Eidos Therapeutics, Inc.EIDXBridgeBio Pharma LLC
10% owner
1,000,000$17.00$17,000,000
2018-06-22
Purchase
Eidos Therapeutics, Inc.EIDXRA CAPITAL MANAGEMENT, LLC
Director
1,058,824$17.00$18,000,008

1

*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*